Conquer Cancer FDN of the American Society of Clinical Oncology

Analysis

Conquer Cancer FDN of the American Society of Clinical Oncology is a registered charity in United States, based in Alexandria, VA. It received its IRS tax-exemption ruling in October 1999, 27 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Conquer Cancer FDN of the American Society of Clinical Oncology reported income of $39.1m and spending of $33.6m, spending 86% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $30.5m to $39.1m (+28%), an average of +6.4% a year. The sharpest change came in the year to December 2022, when income rose by 34%. Over the whole period it spent 90% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Conquer Cancer FDN of the American Society of Clinical Oncology sits at the 92nd percentile: it is larger than about 92% of them. Against every charity in United States with reported income it ranks in the 98th percentile, and in the 98th percentile within VA. Charities of a similar size with the same main cause include Community Health Centers of Burlington Inc ($39.1m), Montefiore Einstein Inc ($39.1m) and Bristol Hospital Multi-Specialty Group ($39.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 88% and program service revenue 3.4% of the total. It paid $359k in professional fundraising fees. At year end it held assets of $110.1m against liabilities of $13.0m, net assets of $97.0m.